A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
December 28, 2020 - 12 minutes
Genfit
Genfit’s Phase III Drug Fails to Treat NASH, But New Players On Horizon
Patients with the chronic liver disease NASH must now wait even longer for an approved…
May 13, 2020 - 4 minutes
The First Approved NASH Therapy?
Genfit is poised to become the first company to get a treatment for NASH to…
July 30, 2019 - 6 minutes
Genfit’s NASH Drug to Be Developed in China in Deal Worth up to €200M
The US-Chinese company Terns Pharmaceuticals will develop and commercialize Genfit’s phase III drug elafibranor for…
June 25, 2019 - 3 minutes
Genfit Gets Ready to Launch Drug for Untreated Liver Disease Raising €120M
After some big failures from its top competitors earlier this year, French company Genfit has…
March 27, 2019 - 3 minutes
NASH Leader goes Pediatric with Clinical Trial Launch in US
The FDA has cleared Genfit to kick off clinical trials to see if its NASH…
January 23, 2018 - 2 minutes
Bored Between the Holidays? Watch these Biotech Videos!
Christmas might have passed, but we have more videos for you to watch on a…
December 28, 2017 - 4 minutes
Genfit Gets €180M Cash Injection to Bring its Pipeline to Market
Elafibranor, Genfit's lead candidate, will continue its march towards the market with the added boost of…
October 17, 2017 - 3 minutes
These Three Fields Are Proving Biotech is The Innovation Powerhouse in Healthcare
Biotech is the best source of innovation in R&D, making its companies the darlings of…
September 26, 2017 - 8 minutes
The Advantage for the First Mover in NASH is Limited, says Genfit
After we reviewed NASH earlier this year, Genfit's CSO, Dean Hum, came to speak at…
July 11, 2017 - 4 minutes
Genfit Delays Phase III Enrollment in the Race for the First NASH Therapy
Genfit has announced that closing of enrollment will be delayed up to 6 months. Will…
April 24, 2017 - 2 minutes
Two Big Pharma Players Team up to Take Over the NASH Space
Allergan has entered a clinical collaboration with Novartis to run a Phase IIb study combining…
April 18, 2017 - 3 minutes
